Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

The selective cyclooxygenase-2 inhibitor mavacoxib (Trocoxil) exerts anti-tumour effects in vitro independent of cyclooxygenase-2 expression levels.

Hurst EA, Pang LY, Argyle DJ.

Vet Comp Oncol. 2019 Feb 15. doi: 10.1111/vco.12470. [Epub ahead of print]

PMID:
30767381
2.

Antibiotic prophylaxis in veterinary cancer chemotherapy: A review and recommendations.

Bisson JL, Argyle DJ, Argyle SA.

Vet Comp Oncol. 2018 Sep;16(3):301-310. doi: 10.1111/vco.12406. Epub 2018 Jun 12. Review.

PMID:
29892997
3.

Development and Evaluation of a Tissue-Engineered Fibrin-based Canine Mitral Valve Three-dimensional Cell Culture System.

Liu MM, Flanagan TC, Jockenhovel S, Black A, Lu CC, French AT, Argyle DJ, Corcoran BM.

J Comp Pathol. 2018 Apr;160:23-33. doi: 10.1016/j.jcpa.2018.02.001. Epub 2018 Mar 31.

PMID:
29729718
4.

Comparative aspects of canine and human inflammatory breast cancer.

Raposo TP, Arias-Pulido H, Chaher N, Fiering SN, Argyle DJ, Prada J, Pires I, Queiroga FL.

Semin Oncol. 2017 Aug;44(4):288-300. doi: 10.1053/j.seminoncol.2017.10.012. Epub 2018 Jan 19. Review.

PMID:
29526258
5.

Carbonic Anhydrase IX (CAIX), Cancer, and Radiation Responsiveness.

Ward C, Meehan J, Gray M, Kunkler IH, Langdon SP, Argyle DJ.

Metabolites. 2018 Feb 10;8(1). pii: E13. doi: 10.3390/metabo8010013. Review.

6.

Notch pathway inhibition targets chemoresistant insulinoma cancer stem cells.

Capodanno Y, Buishand FO, Pang LY, Kirpensteijn J, Mol JA, Argyle DJ.

Endocr Relat Cancer. 2018 Feb;25(2):131-144. doi: 10.1530/ERC-17-0415. Epub 2017 Nov 24.

PMID:
29175872
7.

Epidermal growth factor receptor activity is elevated in glioma cancer stem cells and is required to maintain chemotherapy and radiation resistance.

Pang LY, Saunders L, Argyle DJ.

Oncotarget. 2017 Aug 3;8(42):72494-72512. doi: 10.18632/oncotarget.19868. eCollection 2017 Sep 22.

8.

Combination toceranib and lomustine shows frequent high grade toxicities when used for treatment of non-resectable or recurrent mast cell tumours in dogs: A European multicentre study.

Bavcar S, de Vos J, Kessler M, de Fornel P, Buracco P, Murphy S, Hirschberger J, Argyle DJ.

Vet J. 2017 Jun;224:1-6. doi: 10.1016/j.tvjl.2017.04.010. Epub 2017 May 3.

9.

Canine Brachycephaly Is Associated with a Retrotransposon-Mediated Missplicing of SMOC2.

Marchant TW, Johnson EJ, McTeir L, Johnson CI, Gow A, Liuti T, Kuehn D, Svenson K, Bermingham ML, Drögemüller M, Nussbaumer M, Davey MG, Argyle DJ, Powell RM, Guilherme S, Lang J, Ter Haar G, Leeb T, Schwarz T, Mellanby RJ, Clements DN, Schoenebeck JJ.

Curr Biol. 2017 Jun 5;27(11):1573-1584.e6. doi: 10.1016/j.cub.2017.04.057. Epub 2017 May 25.

10.

Challenges and opportunities for monoclonal antibody therapy in veterinary oncology.

Beirão BC, Raposo T, Jain S, Hupp T, Argyle DJ.

Vet J. 2016 Dec;218:40-50. doi: 10.1016/j.tvjl.2016.11.005. Epub 2016 Nov 16. Review.

PMID:
27938708
11.

Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy.

Pang LY, Hurst EA, Argyle DJ.

Stem Cells Int. 2016;2016:2048731. Epub 2016 Nov 1. Review.

12.

Canine and feline lymphoma: challenges and opportunities for creating a paradigm shift.

Argyle DJ, Pecceu E.

Vet Comp Oncol. 2016 Aug;14 Suppl 1:1-7. doi: 10.1111/vco.12253. No abstract available.

PMID:
27505685
13.

Veterinary oncology: Biology, big data and precision medicine.

Pang LY, Argyle DJ.

Vet J. 2016 Jul;213:38-45. doi: 10.1016/j.tvjl.2016.03.009. Epub 2016 Mar 11. Review.

PMID:
27240913
14.

Dual targeting of EGFR and ERBB2 pathways produces a synergistic effect on cancer cell proliferation and migration in vitro.

Gray ME, Lee S, McDowell AL, Erskine M, Loh QTM, Grice O, Argyle DJ, Bergkvist GT.

Vet Comp Oncol. 2017 Sep;15(3):890-909. doi: 10.1111/vco.12230. Epub 2016 May 27.

PMID:
27229930
15.

Erratum to: A Comparative Study on the In Vitro Effects of the DNA Methyltransferase Inhibitor 5-Azacytidine (5-AzaC) in Breast/Mammary Cancer of Different Mammalian Species.

Harman RM, Curtis TM, Argyle DJ, Coonrod SA, Van de Walle GR.

J Mammary Gland Biol Neoplasia. 2016 Jun;21(1-2):67-68. No abstract available.

PMID:
27116467
16.

Immunohistochemical Expression of CCR2, CSF1R and MMP9 in Canine Inflammatory Mammary Carcinomas.

Raposo TP, Beirão BC, Pires I, Prada J, Brilhante P, Argyle DJ, Queiroga FL.

Anticancer Res. 2016 Apr;36(4):1805-13.

PMID:
27069163
17.

A Comparative Study on the In Vitro Effects of the DNA Methyltransferase Inhibitor 5-Azacytidine (5-AzaC) in Breast/Mammary Cancer of Different Mammalian Species.

Harman RM, Curtis TM, Argyle DJ, Coonrod SA, Van de Walle GR.

J Mammary Gland Biol Neoplasia. 2016 Jun;21(1-2):51-66. doi: 10.1007/s10911-016-9350-y. Epub 2016 Mar 22. Review. Erratum in: J Mammary Gland Biol Neoplasia. 2016 Jun;21(1-2):67-8.

PMID:
27002722
18.

In vitro models for the study of osteoarthritis.

Johnson CI, Argyle DJ, Clements DN.

Vet J. 2016 Mar;209:40-9. doi: 10.1016/j.tvjl.2015.07.011. Epub 2015 Jul 14. Review.

19.

Exploring new biomarkers in the tumour microenvironment of canine inflammatory mammary tumours.

Raposo TP, Pires I, Prada J, Queiroga FL, Argyle DJ.

Vet Comp Oncol. 2017 Jun;15(2):655-666. doi: 10.1111/vco.12209. Epub 2016 Jan 17.

PMID:
26778136
20.

INVITED REVIEW--IMAGE REGISTRATION IN VETERINARY RADIATION ONCOLOGY: INDICATIONS, IMPLICATIONS, AND FUTURE ADVANCES.

Feng Y, Lawrence J, Cheng K, Montgomery D, Forrest L, Mclaren DB, McLaughlin S, Argyle DJ, Nailon WH.

Vet Radiol Ultrasound. 2016 Mar-Apr;57(2):113-23. doi: 10.1111/vru.12342. Epub 2016 Jan 18. Review.

PMID:
26777133

Supplemental Content

Loading ...
Support Center